Literature DB >> 7501642

Ribosomes of Leishmania are a target for the aminoglycosides.

M Maarouf1, F Lawrence, S L Croft, M Robert-Gero.   

Abstract

Ribosomes of Leishmania, a parasitic protozoan (member of the order of Kinetoplastidae), were purified on a sucrose density gradient. Two different types of ribosomes were isolated from the promastigotes: cytoplasmic (88S and 91S from L. tropica and L. donovani, respectively) and mitochondrial (75S in both species). Both types of ribosome dissociated into their subunits at low Mg2+ concentration (1-2 mM) as follows: 67S and 49S for the 91S cytoplasmic ribosomes of L. donovani and 61S and 43S for the 88S cytoplasmic ribosome of L. tropica; 55S and 34S for L. tropica and 60S and 39S for L. donovani mitochondrial ribosomes, respectively. Paromomycin (aminosidine), an aminoglycoside aminocyclitol antibiotic, interacted with the ribosomes to promote the association of the subunits. Under similar experimental conditions, spermidine and pentamidine were inactive.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7501642     DOI: 10.1007/bf00931504

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  24 in total

1.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

2.  Effect of modeccin on the steps of peptide-chain elongation.

Authors:  L Montanaro; S Sperti; M Zamboni; M Denaro; G Testoni; A Gasperi-Campani; F Stirpe
Journal:  Biochem J       Date:  1978-11-15       Impact factor: 3.857

3.  Ribosome-inactivating proteins from plants inhibit ribosome activity of Trypanosoma and Leishmania.

Authors:  P Cenini; A Bolognesi; F Stirpe
Journal:  J Protozool       Date:  1988-08

4.  Primary structure of the Leishmania donovani small subunit ribosomal RNA coding region.

Authors:  D Looker; L A Miller; H J Elwood; S Stickel; M L Sogin
Journal:  Nucleic Acids Res       Date:  1988-07-25       Impact factor: 16.971

5.  Effect of streptomycin on the response of Escherichia coli ribosomes to the dissociation factor.

Authors:  B J Wallace; P C Tai; B D Davis
Journal:  J Mol Biol       Date:  1973-04-05       Impact factor: 5.469

6.  Protein synthesis by cell-free extracts of Crithidia oncopelti.

Authors:  J K Chesters
Journal:  Biochim Biophys Acta       Date:  1966-02-21

7.  [Monomycin therapy of patients with acute necrotizing cutaneous leishmaniasis].

Authors:  T A Arustamian
Journal:  Vestn Dermatol Venerol       Date:  1967-10

8.  Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride.

Authors:  J el-On; L Weinrauch; R Livshin; Z Even-Paz; G P Jacobs
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-14

Review 9.  Recent advances in the treatment of visceral leishmaniasis.

Authors:  R N Davidson; S L Croft
Journal:  Trans R Soc Trop Med Hyg       Date:  1993 Mar-Apr       Impact factor: 2.184

10.  Isolation of kinetoplast-mitochondrial complexes from Leishmania tarentolae.

Authors:  P Braly; L Simpson; F Kretzer
Journal:  J Protozool       Date:  1974-11
View more
  17 in total

1.  In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.

Authors:  Karin Seifert; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 2.  Drug resistance in leishmaniasis.

Authors:  Simon L Croft; Shyam Sundar; Alan H Fairlamb
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Synthesis and Evaluation of Methyl 4-(7-Hydroxy-4,4,8-Trimethyl-3-Oxabicyclo[3.3.1]Nonan-2-yl)Benzoate as an Antileishmanial Agent and Its Synergistic Effect with Miltefosine.

Authors:  Prachi Bhalla; Sabera Sultana; Adarsh Kumar Chiranjivi; Anil K Saikia; Vikash Kumar Dubey
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

Authors:  Antara Banerjee; Manjarika De; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

5.  Differential effects of paromomycin on ribosomes of Leishmania mexicana and mammalian cells.

Authors:  Marisa M Fernández; Emilio L Malchiodi; Israel D Algranati
Journal:  Antimicrob Agents Chemother       Date:  2010-10-18       Impact factor: 5.191

6.  Paromomycin: uptake and resistance in Leishmania donovani.

Authors:  Anupam Jhingran; Bhavna Chawla; Shailendra Saxena; Michael Peter Barrett; Rentala Madhubala
Journal:  Mol Biochem Parasitol       Date:  2008-12-25       Impact factor: 1.759

7.  Drug resistance in leishmaniasis.

Authors:  Jaya Chakravarty; Shyam Sundar
Journal:  J Glob Infect Dis       Date:  2010-05

8.  Identification of the molecular attributes required for aminoglycoside activity against Leishmania.

Authors:  Moran Shalev; Jiro Kondo; Dmitry Kopelyanskiy; Charles L Jaffe; Noam Adir; Timor Baasov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

Review 9.  Leishmaniasis: where are we and where are we heading?

Authors:  Santanu Sasidharan; Prakash Saudagar
Journal:  Parasitol Res       Date:  2021-04-07       Impact factor: 2.289

10.  Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance.

Authors:  Elvira Cynthia Alves Horácio; Jéssica Hickson; Silvane Maria Fonseca Murta; Jeronimo Conceição Ruiz; Laila Alves Nahum
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.